Back to Trades
Roberts Brandi
Chief Financial OfficerCIK 0001516354
Total Volume
$259.2K
6 filings
Purchases
$0
0 buy txns
Sales
$259.2K
2 sell txns
Net Activity
-$259.2K
net sold
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 6
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2026
Across 6 filings between 2026, Roberts Brandi, Chief Financial Officer, has disclosed $259.2K in transactions — all concentrated in Definium Therapeutics, Inc. (DFTX). Their disclosed trades are heavily weighted toward selling — $0 in buys and $259.2K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Sep 29 | DFTX Definium Therapeutics, Inc. | Roberts Brandi | Chief Financial Officer | Sell | $123.5K |
| Sep 14 | DFTX Definium Therapeutics, Inc. | Roberts Brandi | Insider | Grant | $0 |
| Aug 12 | DFTX Definium Therapeutics, Inc. | Roberts Brandi | Insider | Grant | $0 |
| Jun 26 | DFTX Definium Therapeutics, Inc. | Roberts Brandi | Insider | Sell | $135.7K |
| Jun 22 | DFTX Definium Therapeutics, Inc. | Roberts Brandi | Insider | Grant | $0 |
| Feb 5 | DFTX Definium Therapeutics, Inc. | Roberts Brandi | Insider | Grant | $0 |
6 filings